适配体在神经肿瘤学中的应用:一种新兴的治疗模式
本文综述适配体在神经肿瘤学中的最新应用报告,包括通过细胞和体内指数富集配体系统进化技术筛选的适配体、适配体靶向治疗递送方式以及适配体在诊断和影像中的应用,并指出推动适配体药物或工具进入临床的关键未来方向。
要点
- 适配体是短单链DNA或RNA寡核苷酸,可折叠成序列特异性三维结构,以高亲和力和特异性与靶标配体相互作用。
- 临床前研究显示适配体可克服传统神经肿瘤治疗无效的一些障碍,潜在优势包括体积小、部分情况下可穿透血脑屏障、固有缺乏免疫原性及可用于发现新生物标志物。
- 本文综述适配体在神经肿瘤学中的近期应用报告,并确定推动适配体药物或工具进入临床的关键未来方向。
核心结论
- 适配体技术近期已应用于神经肿瘤学,作为创新治疗的潜在方法,临床前研究显示其能克服传统神经肿瘤治疗无效的一些障碍。
研究设计与样本
- 综述,回顾近期适配体在神经肿瘤学中应用的报告,包括通过细胞和体内指数富集配体系统进化技术筛选的适配体、适配体靶向治疗递送方式以及适配体在诊断和影像中的应用。
主要发现
- 适配体的潜在优势包括体积小、部分情况下可穿透血脑屏障、固有缺乏免疫原性以及可用于发现新生物标志物。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite recent advances in the understanding of brain tumor pathophysiology, challenges associated with tumor location and characteristics have prevented significant improvement in neuro-oncology therapies. Aptamers are short, single-stranded DNA or RNA oligonucleotides that fold into sequence-specific, 3-dimensional shapes that, like protein antibodies, interact with targeted ligands with high affinity and specificity. Aptamer technology has recently been applied to neuro-oncology as a potential approach to innovative therapy. Preclinical research has demonstrated the ability of aptamers to overcome some obstacles that have traditionally rendered neuro-oncology therapies ineffective. Potential aptamer advantages include their small size, ability in some cases to penetrate the blood-brain barrier, inherent lack of immunogenicity, and applicability for discovering novel biomarkers. Herein, we review recent reports of aptamer applications in neuro-oncology including aptamers found by cell- and in vivo- Systematic Evolution of Ligands by Exponential Enrichment approaches, aptamer-targeted therapeutic delivery modalities, and aptamers in diagnostics and imaging. We further identify crucial future directions for the field that will be important to advance aptamer-based drugs or tools to clinical application in neuro-oncology.
引用
- Doherty C, Wilbanks B, Khatua S, et al. Aptamers in neuro-oncology: An emerging therapeutic modality. Neuro Oncol. 2024. PMID: 37619244. doi:10.1093/neuonc/noad156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。